Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: Are more deals at the end of q2 possible?

Me, too!

This silence acts like poison to the share price. We even don't know if it is part of the game. I am really confused of what's going on. However, we haven't heard somting negative from Pohl. But silcens is turned from the market into negative.

GTLA

S42005

Share
New Message
Please login to post a reply